# A Study of the NeoVista Ophthalmic System for the Treatment of Subfoveal CNV Associated With Wet AMD in Patients That Require Persistent Anti-VEGF Therapy

> **NCT00809419** · PHASE1,PHASE2 · UNKNOWN · sponsor: **NeoVista** · enrollment: 32 (estimated)

## Conditions studied

- Age Related Macular Degeneration

## Interventions

- **DEVICE:** NeoVista Ophthalmic System

## Key facts

- **NCT ID:** NCT00809419
- **Lead sponsor:** NeoVista
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-11
- **Primary completion:** 2012-11
- **Final completion:** 2012-11
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2011-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00809419

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00809419, "A Study of the NeoVista Ophthalmic System for the Treatment of Subfoveal CNV Associated With Wet AMD in Patients That Require Persistent Anti-VEGF Therapy". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT00809419. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*